ReviewJournal of ophthalmology2026
Nutraceutical Intervention of Probiotics in Vision Science: A Systematic Review of Evolving Perspective.
Review in Journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nutraceutical Intervention of Probiotics in Vision Science: A Systematic Review of Evolving Perspective.Journal of ophthalmology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Probiotics are active elements of the gastrointestinal tract that, when administered in adequate quantities, confer prolonged health efficacy on host organisms by enhancing the equilibrium of their gut microbiota (GM). This GM regulates numerous aspects of human wellness and is required for sustaining metabolic equilibrium. A gut-eye axis is a bidirectional mechanism that suggests an interaction between intestinal microbiota and the eyes, which is robust to microbial cultures like ocular surface microbiota (OSM). This review integrated PubMed, Scopus, and Web of Science through a systematic approach and probed the therapeutic efficacy of the human microbiota against the gut-eye homeostasis, which enables the invasion and growth of bacteria in the ocular region, triggering inflammation and deranging regional intestinal immune stability, molecular resemblance, and the subsequent decrease of acceptability concerning ocular antigens. Immunomodulation of the microenvironment and improving the human gut microbiota (HGM) are keys to reducing infections. Probiotics with antibacterial properties, unlike microorganisms that induce eye infections, may significantly reduce infections, making them a potential alternative to antibiotics. The antibacterial activity of probiotic strains significantly reduced bacterial growth, suggesting clinical promise for some chronic neurodegenerative diseases related to commensal bacteria, particularly through immune modulation, nutritional competition, or inhibitory chemical production. Well-designed clinical experiments in future could explore the antimicrobial spectrum of each strain and how probiotics respond to different pathogens. With optimal delivery methods, an evaluator will likely pave the way for personalized probiotic intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.